Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5186759
Max Phase: Preclinical
Molecular Formula: C9H12N5Na2O6P
Molecular Weight: 319.21
Associated Items:
ID: ALA5186759
Max Phase: Preclinical
Molecular Formula: C9H12N5Na2O6P
Molecular Weight: 319.21
Associated Items:
Canonical SMILES: Nc1nc2c(ncn2CCOCC(O)P(=O)([O-])[O-])c(=O)[nH]1.[Na+].[Na+]
Standard InChI: InChI=1S/C9H14N5O6P.2Na/c10-9-12-7-6(8(16)13-9)11-4-14(7)1-2-20-3-5(15)21(17,18)19;;/h4-5,15H,1-3H2,(H2,17,18,19)(H3,10,12,13,16);;/q;2*+1/p-2
Standard InChI Key: ZBFSLWYERVHPCU-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 319.21 | Molecular Weight (Monoisotopic): 319.0682 | AlogP: -1.79 | #Rotatable Bonds: 6 |
Polar Surface Area: 176.58 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.26 | CX Basic pKa: 0.36 | CX LogP: -3.25 | CX LogD: -5.41 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.30 | Np Likeness Score: -0.40 |
1. Klejch T, Keough DT, King G, Doleželová E, Česnek M, Buděšínský M, Zíková A, Janeba Z, Guddat LW, Hocková D.. (2022) Stereo-Defined Acyclic Nucleoside Phosphonates are Selective and Potent Inhibitors of Parasite 6-Oxopurine Phosphoribosyltransferases., 65 (5.0): [PMID:35175749] [10.1021/acs.jmedchem.1c01881] |
Source(1):